Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFR
Clinical trial NCT00567359 · COMPLETED
Trial details
- NCT number
- NCT00567359
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2017-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.